Medicinal Genomics

NOVEMBER 12, 2024

As a result, labs that have received a state license to test either medical or recreational cannabis have historically been denied a DEA Schedule I license to test hemp under the 2018 Farm Bill. However, this may change with rescheduling that is going to be revisited on Dec 2, 2024.

Compliance 52

Compliance Compliance Data Agriculture 52

Cannabis Law Report

MAY 31, 2022

The only opportunity to currently participate would be through an active clinical trial or via an argument under the Right to Try Act of 2018 (an act which provides a pathway for patients with life-threatening diseases or conditions to access unapproved treatments). Emerging Non-Medical State-Regulated Path. View source.].

Clinical Trials 52

Clinical Trials Legalization Therapy Decriminalization 52

The Cannigma

MAY 15, 2023

While costs to access ketamine therapy can be high in some locations, and like any drug ketamine is not a cure-all, some patients and their doctors have been reporting life-changing results when no other treatment provided relief. The post How to access and assess ketamine therapy options appeared first on The Cannigma.

Therapy 82

Therapy Access Blood Pressure Treatment 82

The Blunt Truth

JANUARY 19, 2024

HHS DOCUMENT RELEASE Last month , the Department of Health and Human Services (HHS) released a heavily redacted version of their recommendation to the Drug Enforcement Administration (DEA) that cannabis be moved from Schedule I to Schedule III. Of course, the DEA will make its own decision, as we noted earlier this month.

DEA 59

DEA Retail Consumption Legalization 59

Kind Meds (Cannabis Education Blog)

FEBRUARY 7, 2022

The DEA still classifies cannabis as a Schedule I controlled substance, a designation reserved for drugs with no medical value and a high potential for abuse. Virginia also legalized cannabis in 2021, but residents can expect to wait until 2024 before they can purchase cannabis products. More States Favor Cannabis Legalization.

Recreational 52

Recreational Data Cannabis DEA 52

Veriheal

NOVEMBER 7, 2024

In May 2024, the U.S. However, the rescheduling process is yet to be finalized, and although some optimistic advocates expected the decision to be fast-tracked before the November 2024 election, the fight for cannabis reform will not be won so quickly. THC content) under federal law, signaling a major shift in the U.S.

DEA 52

DEA Policy Chronic Pain Marijuana 52

Veriheal

NOVEMBER 4, 2024

While many people want recreational weed legalized simply so they have easier access to it, passing this law would open up economic opportunities, expunge criminal records, and create jobs for people of color who have been historically disenfranchised by cannabis criminalization. It is scheduled at the same level as heroin.”

Events 109

Events Topical DEA Cannabis 109

The Blunt Truth

DECEMBER 22, 2023

UNITED STATES ATTORNEYS Attorney General Merrick Garland and DEA Administrator Anne Milgram received a letter this week from several former United States Attorneys. It seems likely that 2024 will bring a decision on re-scheduling, either for or against, so stay tuned for that. Look for more on this in 2024 also.

DEA 52

DEA Retail Programs Hemp 52